<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

<address id="pfpd9"><var id="pfpd9"></var></address>
<sub id="pfpd9"><var id="pfpd9"></var></sub>

<thead id="pfpd9"><var id="pfpd9"><ins id="pfpd9"></ins></var></thead>

<address id="pfpd9"><listing id="pfpd9"></listing></address>

<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

    <thead id="pfpd9"><var id="pfpd9"><output id="pfpd9"></output></var></thead><sub id="pfpd9"><var id="pfpd9"><ins id="pfpd9"></ins></var></sub><sub id="pfpd9"></sub>
    <address id="pfpd9"></address><address id="pfpd9"></address>

    <sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

      Areas of Interest

      Bristol-Myers Squibb seeks Independent Research applications across all therapeutic areas.? Our Areas of interest outlines additional criteria to help guide the scientific community.? All concept applications submitted that best align with our interest will be considered & evaluated.

      The criteria will include, but not be limited to:

      • Specific therapeutic area of interest
      • The type of science we are seeking
      • We may include a specific windows of time for all concept applications to be submitted.

      We also post general requests for proposals (RFPs) that do not have the same type of restrictions as the Competitive Research Grant process.

      Filter to find Areas of Interest:

      Competitive Research Grants

      The Bristol-Myers Squibb Competitive Research Grant process includes the submission of a concept application that meets the required criteria posted. Competitive Research Grants we post will include specific criteria that must be met for your application to be considered.
      At this time, there are no competitive research grants available.
      Click here?for trademark information on Bristol-Myers Squibb products.
      Please click on product name to see the Full U.S. Prescribing Information for ELIQUIS?, EMPLICITI?, NULOJIX?, OPDIVO?, ORENCIA?, SPRYCEL?, YERVOY?, including Boxed WARNINGS for ELIQUIS?, NULOJIX?, and Boxed WARNING for YERVOY? regarding immune-mediated adverse reactions.

      Begin a New Application

      If interested in a product or an investigational compound not listed